Multiple sclerosis progression: time for a new mechanism-driven frameworkTanja Kuhlmann, Emmaunelle Waubant, Marcello Moccia et al.|The Lancet Neurology|2022Cited by 624
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteriaXavier Montalbán, Heinz Wiendl, Christine Lebrun‐Frénay et al.|The Lancet Neurology|2025Cited by 314
COVID-19 in people with multiple sclerosis: A global data sharing initiativeLiesbet M. Peeters, Nick Rijke, Daniele Raimondi et al.|Multiple Sclerosis Journal|2020Cited by 63
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple SclerosisIzanne Roos, Vincent Van Pesch, Stella Hughes et al.|JAMA Neurology|2023Cited by 62
Updated Results of the COVID-19 in MS Global Data Sharing InitiativeSteve Simpson, Liesbet M. Peeters, Ashkan Pirmani et al.|Neurology Neuroimmunology & Neuroinflammation|2022Cited by 53